Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | March 20, 2013

Post-Grant Alert: New PTO Fees Effective March 19, 2013

Blog | March 18, 2013

USPTO Clarifies "Routine Discovery" Permitted in Patent Trials Before the PTAB

Article | March 15, 2013

Yoga, exercise or dance?

Q&A | March 12, 2013

Q&A With Fish's Michael McKeon

Blog | March 11, 2013

Patent Trial and Appeal Board's decision in Macauto U.S.A. provides clarity on some inter partes review requirements

Blog | March 07, 2013

USPTO declines petition for inter partes review - marking the first time since the proceeding has become available under AIA

Article | March 05, 2013

1st-To-File System Isn't New To Drug Companies

Article | February 28, 2013

Boston Business Journal on iRobot and its patents - what makes them strong?

Blog | February 26, 2013

Fish Alert: 'Trademark Clearinghouse' for New gTLDs to Open March 26

Blog | February 22, 2013

DDEL addresses EMVR vs. smallest salable unit and comparability of portfolio licenses

Blog | February 18, 2013

NDTX continues trial to allow plaintiff's damages expert to address issues in damages theory

Blog | February 14, 2013

DDEL approves case-by-case approach to discovery of license negotiation documents